- Training
- 90 Minutes
Global
- Report
- September 2023
- 83 Pages
Global
From €3500EUR$4,294USD£3,136GBP
- Report
- February 2022
- 91 Pages
Global
From €3200EUR$3,926USD£2,867GBP
- Report
- January 2025
- 132 Pages
Global
From €829EUR$950USD£718GBP
- Webinar
- 60 Minutes
Global
From €166EUR$190USD£144GBP
Bioburden is a term used in biotechnology to refer to the number of viable microorganisms present in a sample. It is an important factor in the production of biopharmaceuticals, medical devices, and other products. Bioburden testing is used to ensure that products are free from contamination and to monitor the quality of the manufacturing process. The bioburden market is composed of companies that provide testing services, equipment, and consumables. These companies offer a range of products and services, including microbial identification, enumeration, and detection.
The bioburden market is highly competitive, with a number of established players and new entrants. Companies in the market include 3M, Merck, Thermo Fisher Scientific, Bio-Rad, and Charles River Laboratories. Show Less Read more